Clinical Trials and Research Studies
Clinical Trials
-
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"
Stanford is currently accepting patients for this trial. -
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Stanford is currently accepting patients for this trial. -
North American Prodromal Synucleinopathy Consortium
Stanford is currently accepting patients for this trial. -
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Stanford is currently accepting patients for this trial. -
Natural History Study of Synucleinopathies
Stanford is currently accepting patients for this trial. -
Bright Light as a Countermeasure for Circadian Desynchrony
Stanford is currently accepting patients for this trial. -
Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease
Stanford is currently accepting patients for this trial. -
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
Stanford is currently accepting patients for this trial.
More Studies
Insomnia Treatment Program
Fiona Barwick, PhD, DBSM
Purpose: This clinical trial investigates three 6-week digital programs, one app-based and two online, for improving sleep in individuals with insomnia. All three programs - Full Sleep, Path to Better Sleep, and Sleep Hygiene Education - are based on cognitive and / or behavioral principles that can improve sleep. All three treatment condition include daily lessons about sleep along with sleep questionnaires, sleep tracking and sleep skills that are delivered either online or through a phone app. In addition, Full Sleep includes a bedside device that will help to track sleep.
Payment offered for participation
Time needed from participant: 15 minutes per day to complete an app-based or online sleep diary and review information in an app-based or online CBT-I program.
To qualify, you must:
- Be 18+ years old
- Have a diagnosis of insomnia or suspected insomnia
- Have access to the internet and an iphone, Android or other smart phone device
Coordinator Contact:
Cris Moreno
(650) 721-7576
crismore@stanford.edu
Applying 3D Upper Airway Ultrasound Imaging to Clinical Diagnosis of Obstructive Sleep Apnea
Purpose: To “see” the airway: how it collapses during snoring for our patients with obstructive sleep apnea remains a challenge. At Stanford, we started a study using ultrasound imaging to “see” your airway in a non-invasive manner without radiation.
PI: Clete Kushida, MD, PhD / Stanley Liu, MD, DDS
Study status: Open, enrollment ongoing
Coordinator Contact:
Neehar Thumaty
neehart@stanford.edu
(650)721-7574
Sleep and Oxygen Levels
Makoto Kawai, MD, D.Sc.
Purpose: to participate in groundbreaking research examining sleep and measures of brain oxygen levels simultaneously.
Payment offered for participation
Time needed from participant:
- Spend 6-8 hours of active participation
- You will be asked to complete one sleep assessment (polysomnography)
To qualify, you must:
- Be a healthy individual, 60+ years old
- Be able to travel to Stanford to complete some questionnaires
Coordinator Contact:
Isabelle Cotto (650) 723-2795
ijoly@Stanford.edu
Upper Airway Training for OSA
Clete Kushida, MD, PhD
Purpose: To see if playing a musical instrument-training program can improve OSA
Inclusion:
- 21-50 years old
- Diagnosis of mild to moderate OSA
- HST scheduled or recently performed
Time needed from participant: Approximately 12 weeks depending on OSA severity
Coordinator Contact:
Adrian Ekelmans (650) 721-5489
adrian01@stanford.edu
UVN-G3031 for Narcolepsy 1 or 2
Emmanuel Mignot, MD, PhD
Purpose: To study the safety and efficacy of study drug SUVN-G3031 as a possible treatment for NT1 and NT2
Inclusion:
- 18-50 years old
- Diagnosis of narcolepsy type 1 or 2
- MSLT within 15 years showing ≤ 8 minutes with 2 or more SOREMPs
- An ESS score of ≥ 12
Time needed from participant: Up to 7 weeks of active participation. At least 5 clinic visits during that period
Coordinator Contact:
Vivian Liu (650) 721-5489
vivian44@stanford.edu
Blood biomarkers study in REM sleep behavior disorder (RBD)
Purpose: studying neuroinflammation and immune protective factors in patients with RBD
Co-PI: Emmanuel Mignot, MD, PhD
Study status: Open, enrollment ongoing
Research Coordinator:
Ana Cahuas (research coordinator) 650 721 5489, acahuas@stanford.edu
Home diagnosis of REM sleep behavior disorder (RBD) using wearable sleep trackers
Purpose: developing a machine learning method to diagnose RBD in the home environment with wrist-worn actigraphy
Study status: Open, enrollment ongoing
Research Coordinator:
Ana Cahuas (research coordinator) 650 721 5489, acahuas@stanford.edu
For more information: https://www.ClinicalTrials.gov
Participant’s right questions, contact: 1-866-680-2906